The Jetstream (JET) Post-market Registry

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 241 participants.

Also called NCT01436435

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 241 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01436435
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01436435. Allocation not applicable; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2016-02 (actual). Results posted on 2016-08-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Jetstream (JET) Post-market Registry
Acronym
JET
Condition
Peripheral Arterial Diseases
Intervention (Device)
Jetstream Atherectomy System
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01436435
Content hash
6602e89fbb61f051a347ccd2d33dd59f5def55b6aad9a0c2bd16ae6faa19a391